Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Proto Labs IncPRLB · Entity 4553 | Chief Financial Officer | September 24, 2026 | September 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Proto Labs Inc
Report date September 24, 2026 · Filed September 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,019 |
Reported balance
After 2026-09-24 transaction · row 1
1 source rowRow 1 · 2026-09-24 · Sale · Disposed 5,000 · Balance 35,019 F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. F2: Reflects the weighted average price of 5,000 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on September 24, 2026, with sale prices ranging from $95.00 to $95.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026.
F2: Reflects the weighted average price of 5,000 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on September 24, 2026, with sale prices ranging from $95.00 to $95.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 25, 2026 20:11 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 5,000 | $95.32 | $476,604.50 |
DisclosureSEC source: 0001628280-26-063573 · wk-form4_1790367067.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,019 F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026. F2 · price: Reflects the weighted average price of 5,000 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on September 24, 2026, with sale prices ranging from $95.00 to $95.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 20:02 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 4,900 | $85.21 | $417,535.37 |
DisclosureSEC source: 0001628280-26-062704 · wk-form4_1789761748.xml · nonDerivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,019 F1 · kind: This transaction was executed pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person on June 5, 2026. F2 · price: Reflects the weighted average price of 4,900 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on September 17, 2026, with sale prices ranging from $85.00 to $85.50 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 20:02 UTC | Proto Labs Inc PRLB · Entity 4553 | SaleCommon Stock | 100 | $85.00 | $8,500.00 |
DisclosureSEC source: 0001628280-26-062704 · wk-form4_1789761748.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,919 F1 · kind: This transaction was executed pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person on June 5, 2026. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:12 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 255 | $71.13 | $18,138.15 |
DisclosureSEC source: 0001628280-26-037725 · wk-form4_1779480750.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,019 Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:16 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 5,605 | $0.00 Strike: $62.63 | $0.00 |
DisclosureSEC source: 0001628280-26-012832 · wk-form4_1772226994.xml · derivative · entry 3 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,605 Underlying: Common Stock · 5,605 shares Expires 2036-02-25 F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2027, and on each February 25th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:16 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 504 | $62.63 | $31,565.52 |
DisclosureSEC source: 0001628280-26-012832 · wk-form4_1772226994.xml · nonDerivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,274 Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:16 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 3,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-012832 · wk-form4_1772226994.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,778 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2027, and on each February 25th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:38 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 1,267 | $67.52 | $85,547.84 |
DisclosureSEC source: 0001628280-26-009131 · wk-form4_1771450693.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,704 Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:48 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,135 | $0.00 Strike: $33.84 | $0.00 |
DisclosureSEC source: 0001894753-26-000003 · form4-02122026_090244.xml · derivative · entry 3 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,135 shares Expires 2026-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:48 UTC | Proto Labs Inc PRLB · Entity 4553 | Exercise / conversionCommon Stock | 3,135 | $33.84 | $106,088.40 |
DisclosureSEC source: 0001894753-26-000003 · form4-02122026_090244.xml · nonDerivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:48 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 6,809 | $53.18 | $362,102.62 |
DisclosureSEC source: 0001894753-26-000003 · form4-02122026_090244.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,836 Read SEC document |
| January 29, 2026 Filed Feb 4, 2026 23:15 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 20,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-005552 · wk-form4_1770246948.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,645 Read SEC document |
| May 20, 2025 Filed May 22, 2025 20:40 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 305 | $40.87 | $12,465.35 |
DisclosureSEC source: 0001628280-25-027303 · wk-form4_1747946405.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,959 Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:34 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 7,931 | $0.00 Strike: $39.61 | $0.00 |
DisclosureSEC source: 0001628280-25-008706 · wk-form4_1740692046.xml · derivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,931 Underlying: Common Stock · 7,931 shares Expires 2035-02-25 F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:34 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 4,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-008706 · wk-form4_1740692046.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,264 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 22:42 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 1,264 | $45.03 | $56,917.92 |
DisclosureSEC source: 0001628280-25-006144 · wk-form4_1739918519.xml · nonDerivative · entry 3 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,845 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 22:42 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 1,098 | $45.03 | $49,442.94 |
DisclosureSEC source: 0001628280-25-006144 · wk-form4_1739918519.xml · nonDerivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,109 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 22:42 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 3,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-006144 · wk-form4_1739918519.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,207 Read SEC document |
| May 20, 2024 Filed May 22, 2024 20:23 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 370 | $31.81 | $11,769.70 |
DisclosureSEC source: 0001437749-24-018007 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,130 Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:07 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 9,616 | $0.00 Strike: $33.52 | $0.00 |
DisclosureSEC source: 0001437749-24-004400 · rdgdoc.xml · derivative · entry 3 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,616 Underlying: Common Stock · 9,616 shares Expires 2034-02-13 F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2025, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:07 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 5,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004400 · rdgdoc.xml · nonDerivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2025, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:07 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 1,018 | $33.52 | $34,123.36 |
DisclosureSEC source: 0001437749-24-004400 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,279 Read SEC document |
| May 20, 2023 Filed May 23, 2023 20:22 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 418 | $32.36 | $13,526.48 |
DisclosureSEC source: 0001437749-23-015592 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,297 Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 21:06 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 3,135 | $0.00 Strike: $33.84 | $0.00 |
DisclosureSEC source: 0001437749-23-003513 · rdgdoc.xml · derivative · entry 5 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,135 Underlying: Common Stock · 3,135 shares Expires 2026-02-14 F4 · derivative.exercise_date: The stock option vests in full on February 13, 2024. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 21:06 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 9,815 | $0.00 Strike: $33.84 | $0.00 |
DisclosureSEC source: 0001437749-23-003513 · rdgdoc.xml · derivative · entry 4 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,815 Underlying: Common Stock · 9,815 shares Expires 2033-02-14 F3 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 21:06 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantPerformance Stock Units · Derivative | 10,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-003513 · rdgdoc.xml · derivative · entry 3 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,343 Underlying: Common Stock · 10,343 shares Expires 2025-12-31 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 21:06 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 5,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-003513 · rdgdoc.xml · nonDerivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,715 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:06 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 553 | $34.23 | $18,929.19 |
DisclosureSEC source: 0001437749-23-003513 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,543 Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:03 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 945 | $26.40 | $24,948.00 |
DisclosureSEC source: 0001437749-22-028403 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,096 Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:03 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantPerformance Stock Units · Derivative | 3,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · derivative · entry 6 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,077 Underlying: Common Stock · 3,077 shares Expires 2024-12-31 F5 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. F5 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:03 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 6,317 | $0.00 Strike: $39.11 | $0.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · derivative · entry 5 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,317 Underlying: Common Stock · 6,317 shares Expires 2032-08-30 F4 · derivative.exercise_date: The stock option vest as to 25% of the shares in four annual installments beginning on February 13, 2023. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:03 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 2,288 | $0.00 Strike: $39.11 | $0.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · derivative · entry 4 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288 Underlying: Common Stock · 2,288 shares Expires 2032-08-30 F3 · derivative.exercise_date: The stock option vest as to 25% of the shares in four annual installments beginning on May 20, 2023. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:03 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 6,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · nonDerivative · entry 3 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,041 F2 · shares: The restricted stock units vest in four annual equal installments beginning on February 13, 2023. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:03 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 2,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · nonDerivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,887 F1 · shares: The restricted stock units vest in four annual equal installments beginning on May 20, 2023. Read SEC document |
| May 23, 2022 Filed May 25, 2022 22:13 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 350 | $45.68 | $15,988.00 |
DisclosureSEC source: 0001437749-22-013566 · rdgdoc.xml · nonDerivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,887 Read SEC document |
| May 23, 2022 Filed Sep 1, 2022 23:03 UTC | Proto Labs Inc PRLB · Entity 4553 | Tax withholdingCommon Stock | 350 | $45.68 | $15,988.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,654 Read SEC document |
| May 18, 2022 Filed May 25, 2022 22:13 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantEmployee Stock Option (right to buy) · Derivative | 2,288 | $0.00 Strike: $44.81 | $0.00 |
DisclosureSEC source: 0001437749-22-013566 · rdgdoc.xml · derivative · entry 3 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288 Underlying: Common Stock · 2,288 shares Expires 2032-05-18 F2 · derivative.exercise_date: The stock option vest as to 25% of the shares in four annual installments beginning on May 20, 2023. Read SEC document |
| May 18, 2022 Filed May 25, 2022 22:13 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 2,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013566 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,237 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on May 20, 2023. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:22 UTC | Proto Labs Inc PRLB · Entity 4553 | GrantCommon Stock | 3,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027846 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,004 F1 · shares: Restricted Stock Units that will vest 100% on December 1, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.